Skip to main content
60°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
OptiNose, Inc. - Common Stock
(NQ:
OPTN
)
9.140
-0.010 (-0.11%)
Streaming Delayed Price
Updated: 2:23 PM EDT, Mar 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about OptiNose, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Optinose Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Highlights
March 26, 2025
From
Optinose, Inc.
Via
GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GB, RDFN, PRA, OPTN on Behalf of Shareholders
March 23, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
OPTINOSE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of OptiNose, Inc. - OPTN
March 21, 2025
From
Kahn Swick & Foti, LLC
Via
Business Wire
Earnings Scheduled For November 12, 2024
November 12, 2024
Via
Benzinga
Insights Ahead: OptiNose's Quarterly Earnings
November 11, 2024
Via
Benzinga
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BECN and OPTN on Behalf of Shareholders
March 21, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
This FedEx Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday
March 21, 2025
Via
Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Beacon Roofing Supply, Inc. (Nasdaq – BECN), Optinose, Inc. (Nasdaq – OPTN), Corporation (Nasdaq – RDFN), Blackboxstocks Inc. (Nasdaq – BLBX)
March 20, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
March 20, 2025
Via
Benzinga
Crude Oil Gains Over 1%; US Weekly Jobless Claims Increase
March 20, 2025
Via
Benzinga
Exposures
Fossil Fuels
Optinose Shares Soar After Merger Agreement With Paratek Pharmaceuticals: Retail Sentiment Takes Flight
March 20, 2025
Paratek will acquire Optniose's outstanding shares for $9 apiece in cash, representing a 50% premium to the stock’s closing trading price of $6 on March 19.
Via
Stocktwits
Dow Gains Over 100 Points; Accenture Shares Plunge After Q2 Results
March 20, 2025
Via
Benzinga
Topics
Stocks
Exposures
US Equities
OPTN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Optinose, Inc. Is Fair to Shareholders
March 20, 2025
From
Halper Sadeh LLC
Via
Business Wire
OptiNose Stock Is Soaring Today: What's Going On?
March 20, 2025
OptiNose Inc (NASDAQ:OPTN) shares are trading higher Thursday after Paratek Pharmaceuticals announced a deal to acquire the company.
Via
Benzinga
Shareholder Alert: The Ademi Firm investigates whether Optinose, Inc. is obtaining a Fair Price for its Public Shareholders
March 20, 2025
From
Ademi & Fruchter LLP
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 20, 2025
Via
Benzinga
Why Five Below Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
March 20, 2025
Via
Benzinga
US Stocks Likely To Open Higher As Fed Says Tariff-Induced Inflation Will Be 'Transitory:' Any Pullback In Equities 'Offers An Opportunity,' Says Expert
March 20, 2025
U.S. stock futures rose on Thursday following the Federal Open Market Committee's decision on Wednesday calling inflation 'transitory'.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Optinose Cancels Fourth Quarter and Full Year 2024 Earnings Call
March 19, 2025
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Announces Reporting Date for Fourth Quarter and Full Year 2024 Financial Results
March 11, 2025
Conference Call and Webcast to be held March 20, 2025, at 8:00 a.m. Eastern Time
From
Optinose, Inc.
Via
GlobeNewswire
Monday's pre-market session: top gainers and losers
February 10, 2025
Wondering what's happening in Monday's pre-market session? Find an overview in this article.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 10, 2025
Via
Benzinga
Optinose Announces Preliminary Unaudited Fourth Quarter 2024 XHANCE Net Revenue of $22.4 Million
January 15, 2025
Preliminary XHANCE prescription growth rate from third quarter to fourth quarter 2024 estimated to be approximately 20%
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Announces 1-for-15 Reverse Stock Split
December 26, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Optinose to Present at the Piper Sandler 36th Annual Healthcare Conference
December 02, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Reports Third Quarter 2024 Financial Results and Recent Operational Highlights
November 12, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Announces Reporting Date for Third Quarter 2024 Financial Results
November 05, 2024
Conference Call and Webcast to be held November 12, 2024, at 8:00 a.m. Eastern Time
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 16, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Appoints Terry Kohler as Chief Financial Officer
October 07, 2024
From
Optinose, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
September 27, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.